Nose-to-Brain Protein Delivery Shows Promise for Protecting Dopamine Neurons in Parkinson’s Models
A new study in BMC Medicine reports that intranasally delivered recombinant BMP2/6 proteins delayed dopaminergic neuron degeneration and improved motor function in mouse models of Parkinsonian ...
Parkinson’s disease has long resisted the sort of precision attack that has transformed other areas of medicine, largely because its central culprit—a protein called alpha-synuclein—sits behind a for ...
A molecule linked to chronic inflammation disrupts the brain's ability to create new neurons, uncovering a pathway with therapeutic potential for neurodegenerative diseases and neurological conditions ...
Hypoglycemia is a medical condition where blood sugar levels drop to dangerous levels. Hypoglycemia can pose life-threatening risks, especially to people with type 1 diabetes who need external insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results